Skip to main content

Table 5 Annual percentage tibial bone expansion from baseline over 24 months

From: Safety, tolerability, clinical, and joint structural outcomes of a single intra-articular injection of allogeneic mesenchymal precursor cells in patients following anterior cruciate ligament reconstruction: a controlled double-blind randomised trial

 

MPC + HA

HA alone

p*

Medial tibial plateau

 6 months

0.8 (3.9)

4.2 (3.4)

0.13

 12 months

–1.9 (4.0)

1.5 (3.6)

0.17

 24 months

0.1 (1.7)

0.8 (0.9)

0.43

Lateral tibial plateau

 6 months

0.4 (4.2)

3.6 (3.6)

0.17

 12 months

–0.2 (4.0)

1.9 (2.8)

0.35

 24 months

–1.8 (2.6)

1.2 (3.5)

0.16

Total tibial plateau

 6 months

0.5 (2.4)

4.0 (2.3)

0.02

 12 months

–1.2 (2.8)

1.7 (2.0)

0.09

 24 months

–0.7 (1.5)

1.0 (1.1)

0.09

  1. Data are reported as mean (SD)
  2. * For difference between two groups using independent samples t test
  3. HA hyaluronan, MPC mesenchymal precursor cell